NASDAQ:LXRX - Lexicon Pharmaceuticals SEC Filings & 10K Form

$3.82
+0.88 (+29.93 %)
(As of 09/18/2019 03:48 PM ET)
Today's Range
$3.06
Now: $3.8199
$3.89
50-Day Range
$1.20
MA: $1.50
$2.92
52-Week Range
$1.13
Now: $3.8199
$11.51
Volume8.01 million shs
Average Volume1.83 million shs
Market Capitalization$405.94 million
P/E RatioN/A
Dividend YieldN/A
Beta0.75

SEC Filings

Lexicon Pharmaceuticals (NASDAQ:LXRX) SEC Filings

DateFilerForm TypeView
09/17/2019
4:36 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:33 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:27 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:23 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
3:03 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
4:02 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:12 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:53 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
6:11 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
6:17 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
4:08 PM
Lexicon Pharmaceuticals (Issuer)
Palantoni Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:07 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:06 PM
Lexicon Pharmaceuticals (Issuer)
NIES ALAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:04 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:03 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:02 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:01 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:00 PM
LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
1:50 PM
Lexicon Pharmaceuticals (Filer)
Form CT ORDER
03/13/2019
6:12 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
4:20 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:19 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:18 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:18 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:17 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:16 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:15 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
10:25 AM
Lexicon Pharmaceuticals (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
Form SC 13G/A
02/08/2019
5:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:13 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:10 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:07 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:05 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:02 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:59 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:52 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
11/01/2018
4:17 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
6:14 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
4:17 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2018
3:31 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2018
6:08 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2018
3:09 PM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
06/26/2018
4:32 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:55 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:56 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:10 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:37 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
6:37 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
4:31 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:31 AM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
05/30/2018
7:53 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:43 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
6:13 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
4:42 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:41 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:40 PM
Lexicon Pharmaceuticals (Issuer)
Palantoni Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:39 PM
Lexicon Pharmaceuticals (Issuer)
NIES ALAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:38 PM
LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:37 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:36 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:35 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
3:56 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2018
4:16 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
6:10 AM
Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/16/2018
6:06 AM
Lexicon Pharmaceuticals (Filer)
Form DEF 14A
03/02/2018
4:12 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:11 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:11 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:09 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:08 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:08 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:07 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
6:07 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2018
3:18 PM
Lexicon Pharmaceuticals (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
Form SC 13G/A
02/12/2018
4:18 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:17 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:14 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:13 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:12 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:11 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:10 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/22/2018
3:39 PM
Lexicon Pharmaceuticals (Filer)
Form CT ORDER
12/05/2017
7:26 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel